Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talicia (RHB-105) vs Active Comparator for H. pylori Eradication
NCT03198507Phase 3Completed
- Sponsor
- RedHill Biopharma
- Start
- Jun 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of omeprazole + amoxicillin + rifabutin in Helicobacter pylori infection (2 arms), sponsored by RedHill Biopharma. Primary endpoint: Number of Participants With Eradication of H. Pylori. Started Jun 2017; status: completed.
02
Drugs
omeprazole + amoxicillin + rifabutin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03198507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03198507.